KRT19 and thyroid gland carcinoma: Lately, Wang et al. [29] reported that in thyroid cancer cells with positive BRAF V600E mutation, increased CK19 expression might promote epithelial–mesenchymal transition (EMT) characterized by decreased E-cadherin and increased N-cadherin expression, resulting in lymph node metastasis.